|
gptkbp:instance_of
|
gptkb:fragrance
|
|
gptkbp:brand
|
gptkb:Ventolin
gptkb:Proventil
Accu Neb
|
|
gptkbp:class
|
gptkb:superhero
|
|
gptkbp:clinical_trial
|
studies on efficacy
studies on safety
relief of bronchospasm
prevention of exercise-induced bronchospasm
|
|
gptkbp:contraindication
|
hypersensitivity to albuterol
|
|
gptkbp:dosage_form
|
metered-dose inhaler
|
|
gptkbp:effective_date
|
gptkb:1991
|
|
gptkbp:form
|
nebulizer solution
|
|
gptkbp:formulation
|
gptkb:superhero
|
|
gptkbp:healthcare
|
gptkb:battle
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pro Air
|
|
gptkbp:indication
|
gptkb:asthma
gptkb:chronic_obstructive_pulmonary_disease_(COPD)
|
|
gptkbp:ingredients
|
gptkb:albuterol_sulfate
|
|
gptkbp:interacts_with
|
MAO inhibitors
diuretics
beta-blockers
tricyclic antidepressants
|
|
gptkbp:invention
|
2025
|
|
gptkbp:manager
|
inhalation
|
|
gptkbp:manufacturer
|
gptkb:Teva_Pharmaceuticals
|
|
gptkbp:marketed_as
|
gptkb:Pro_Air_Digihaler
gptkb:Pro_Air_HFA
gptkb:Pro_Air_Respi_Click
|
|
gptkbp:pharmacokinetics
|
rapid onset of action
short duration of action
beta-2 adrenergic agonist
|
|
gptkbp:population
|
shake well before use
do not exceed recommended dose
use as needed for asthma symptoms
|
|
gptkbp:previous_name
|
albuterol
|
|
gptkbp:provides_information_on
|
recommended for COPD management
recommended for asthma management
|
|
gptkbp:requires
|
prescription only
|
|
gptkbp:shelf_life
|
12 months
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
dry mouth
nervousness
tremors
palpitations
muscle cramps
throat irritation
tachycardia
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type_of_care
|
important for COPD control
important for asthma control
|
|
gptkbp:bfsParent
|
gptkb:Ventolin
|
|
gptkbp:bfsLayer
|
6
|